Nik L. Kruisbergen
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Intensive cholesterol-lowering treatment reduces synovial inflammation during early collagenase-induced osteoarthritis, but not pathology at end-stage disease in female dyslipidemic E3L.CETP mice.
Journal: Osteoarthritis and cartilage
Published: July 28, 2022
IL-1β inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model.
Journal: Osteoarthritis and cartilage
Published: April 13, 2022
Activation of circulating monocytes by low-density lipoprotein-a risk factor for osteoarthritis?
Journal: Rheumatology (Oxford, England)
Published: November 23, 2021
Nox2 Deficiency Reduces Cartilage Damage and Ectopic Bone Formation in an Experimental Model for Osteoarthritis.
Journal: Antioxidants (Basel, Switzerland)
Published: September 09, 2021
A single dose of anti-IL-1β antibodies prevents Western diet-induced immune activation during early stage collagenase-induced osteoarthritis, but does not ameliorate end-stage pathology.
Journal: Osteoarthritis and cartilage
Published: January 27, 2021
Novel high-intensive cholesterol-lowering therapies do not ameliorate knee OA development in humanized dyslipidemic mice.
Journal: Osteoarthritis and cartilage
Published: May 29, 2020
Fc-gamma receptors and S100A8/A9 cause bone erosion during rheumatoid arthritis. Do they act as partners in crime?
Journal: Rheumatology (Oxford, England)
Published: December 30, 2018
High LDL-C levels attenuate onset of inflammation and cartilage destruction in antigen-induced arthritis.
Journal: Clinical and experimental rheumatology
Published: November 27, 2018
The role of NOX2-derived reactive oxygen species in collagenase-induced osteoarthritis.
Journal: Osteoarthritis and cartilage
Published: December 23, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026